Transcriptomics-driven metabolic pathway analysis reveals similar alterations in lipid metabolism in mouse MASH model and human
Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent chronic liver disease worldwide, and can rapidly progress to metabolic dysfunction-associated steatohepatitis (MASH). Accurate preclinical models and methodologies are needed to understand underlying...
Main Authors: | Sofia Tsouka, Pavitra Kumar, Patcharamon Seubnooch, Katrin Freiburghaus, Marie St-Pierre, Jean-François Dufour, Mojgan Masoodi |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-03-01
|
Series: | Communications Medicine |
Online Access: | https://doi.org/10.1038/s43856-024-00465-3 |
Similar Items
-
Characterisation of hepatic lipid signature distributed across the liver zonation using mass spectrometry imaging
by: Patcharamon Seubnooch, et al.
Published: (2023-06-01) -
Metabolic Pathway Analysis: Advantages and Pitfalls for the Functional Interpretation of Metabolomics and Lipidomics Data
by: Sofia Tsouka, et al.
Published: (2023-01-01) -
Mashing Maps
by: Rachael E. Barlow
Published: (2008-06-01) -
Carboxylesterases in lipid metabolism: from mouse to human
by: Jihong Lian, et al.
Published: (2017-07-01) -
Cold mash in brewer wort with low carbohydrate content: a study of the mashing step
by: Gabriela Dalberto, et al.
Published: (2023-11-01)